LEAMINGTON, ON, Sept. 14, 2018 /CNW/ - Aphria Inc.
("Aphria" or the "Company") (TSX: APH and
US OTC: APHQF) today announced that Dennis Staudt has resigned from the Company's
Board of Directors (the "Board"). Mr. Staudt served as Lead
Independent Director and Chair of the Audit Committee, and he had
been a member of the Board since 2014, before the company was
publicly traded.
"Dennis has been an integral part of Aphria since the Company's
infancy, and we are tremendously grateful for his dedicated
service, counsel and guidance over the past 4 years," said
Vic Neufeld, Chief Executive Officer
of Aphria. "We thank Dennis for his significant contribution to
Aphria's incredible growth story and ongoing success, and we wish
him well in his future endeavors.
The Company has also announced that the Board has approved the
appointment of John Herhalt to
replace Mr. Staudt as an independent director. Mr. Herhalt is a
retired partner from KPMG and has over 39 years of experience
providing a wide variety of advisory and audit services to a range
of clients. He has also been appointed Chair of the Audit
Committee.
"We are pleased to welcome John to the Aphria family as a member
of our Board of Directors, "added Neufeld. "John brings a wealth of
global experience across a broad base of industry sectors including
consumer products, health care, infrastructure and the public
sector. Aphria will greatly benefit from his incredible knowledge,
experience and strategic guidance ".
The Board will select a new Lead Independent Director following
the AGM.
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an
unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington,
Ontario – the greenhouse capital of Canada – Aphria has been setting the standard
for the low-cost production of safe, clean and pure
pharmaceutical-grade cannabis at scale, grown in the most natural
conditions possible. Focusing on untapped opportunities and backed
by the latest technologies, Aphria is committed to bringing
breakthrough innovation to the global cannabis market. The
Company's portfolio of brands is grounded in expertly-researched
consumer insights designed to meet the needs of every consumer
segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term
shareholder value through a diversified approach to innovation,
strategic partnerships and global expansion, with a presence in
more than 10 countries across 5 continents.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to internal expectations,
estimated margins, expectations with respect to actual production
volumes, expectations for future growing capacity and costs, the
completion of any capital project or expansions, and expectations
with respect to future production costs. Forward-looking statements
necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions;
adverse industry events; marketing costs; loss of markets; future
legislative and regulatory developments involving medical
marijuana; inability to access sufficient capital from internal and
external sources, and/or inability to access sufficient capital on
favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory
matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate
fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
SOURCE Aphria Inc.